Maziar Mike Doustdari

Maziar Mike Doustdari is a business executive known for his leadership in the pharmaceutical industry. Recently appointed as the new CEO of Novo Nordisk, he takes the helm during a challenging period for the company, which has seen a decline in its market position due to increased competition from rivals like Eli Lilly. Doustdari's experience and strategic vision are anticipated to guide Novo Nordisk as it navigates the evolving landscape of weight loss medications and seeks to regain its competitive edge.